Home/Pipeline/Venglustat

Venglustat

Type 3 Gaucher disease

Phase 3Breakthrough Therapy designation

Key Facts

Indication
Type 3 Gaucher disease
Phase
Phase 3
Status
Breakthrough Therapy designation
Company

About Sanofi

Sanofi is one of the world's largest pharmaceutical companies, leveraging artificial intelligence and deep immunology expertise to develop breakthrough treatments and vaccines. With a comprehensive pipeline spanning multiple therapeutic areas and a strong commercial portfolio of established medicines, the company is committed to improving global health outcomes. Their recent focus on AI-powered drug discovery and development positions them at the forefront of pharmaceutical innovation.

View full company profile